Table 7 |
||||
|
Trends in chloroquine sensitivity profiles during periods of co-administration of antihistamines with chloroquine or use of sub-therapeutic dosage regimen in patients from a private hospital in Ibadan, south-west Nigeria |
||||
|
Year |
Frequency of co-administration of antihistamine |
Frequency of prescription of Full course regimen |
Frequency of sub-therapeutic regimen |
Reported chloroquine sensitivity |
|
|
||||
|
1983 (N = 289) |
74.7% |
93.1% |
6.9% |
|
|
|
||||
|
1985 (N = 298) |
80.0% |
98.3% |
1.7% |
|
|
|
||||
|
1987 (N = 295) |
84.4% |
96.3% |
3.7% |
100% [21] |
|
|
||||
|
1989 (N = 220) |
72.3% |
97.3% |
2.7% |
|
|
|
||||
|
1992 (N = 258) |
67.4% |
78.3% |
21.7% |
85% [22] |
|
|
||||
|
1995 (N = 243) |
48.6% |
72.8% |
27.2% |
|
|
|
||||
|
1997 (N = 241) |
51.9% |
56.4% |
43.6% |
<40%([3] |
|
|
||||
|
Gbotosho et al. Malaria Journal 2009 8:313 doi:10.1186/1475-2875-8-313 |
||||
